-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Guardant Health, Raises Price Target to $175

Benzinga·06/08/2026 17:29:58
Listen to the news
Mizuho analyst Anthony Petrone maintains Guardant Health (NASDAQ:GH) with a Outperform and raises the price target from $135 to $175.